Organogenesis Holdings Inc. Return On Equity in % from Q2 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Organogenesis Holdings Inc. quarterly/annual Return On Equity history and growth rate from Q2 2017 to Q3 2025.
  • Organogenesis Holdings Inc. Return On Equity for the quarter ending September 30, 2025 was 0.4 %.
  • Organogenesis Holdings Inc. annual Return On Equity for 2024 was 0.32 %, a 82.7% decline from 2023.
  • Organogenesis Holdings Inc. annual Return On Equity for 2023 was 1.81 %, a 70.3% decline from 2022.
  • Organogenesis Holdings Inc. annual Return On Equity for 2022 was 6.1 %, a 87.7% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Organogenesis Holdings Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 0.4 +3.09 Jul 1, 2025 Sep 30, 2025
Q2 2025 -3.24 +2.8 +46.4% Apr 1, 2025 Jun 30, 2025
Q1 2025 -6.06 -8.17 -388% Jan 1, 2025 Mar 31, 2025
Q4 2024 0.32 -1.5 -82.7% Oct 1, 2024 Dec 31, 2024
Q3 2024 -2.69 -7.51 -156% Jul 1, 2024 Sep 30, 2024
Q2 2024 -6.03 -9.84 -259% Apr 1, 2024 Jun 30, 2024
Q1 2024 2.1 -3.08 -59.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 1.81 -4.29 -70.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 4.83 -18.9 -79.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 3.8 -27 -87.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 5.18 -34.2 -86.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 6.1 -43.6 -87.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 23.8 -13.4 -36% Jul 1, 2022 Sep 30, 2022
Q2 2022 30.8 -21.4 -41% Apr 1, 2022 Jun 30, 2022
Q1 2022 39.4 -5.46 -12.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 49.7 +24.7 +98.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 37.2 +44.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 52.3 +154 Apr 1, 2021 Jun 30, 2021
Q1 2021 44.8 +168 Jan 1, 2021 Mar 31, 2021
Q4 2020 25 +153 Oct 1, 2020 Dec 31, 2020
Q3 2020 -7.28 +160 +95.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -102 +165 +61.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -123 -2.73K -105% Jan 1, 2020 Mar 31, 2020
Q4 2019 -128 -457 -139% Oct 1, 2019 Dec 31, 2019
Q3 2019 -167 -346 -193% Jul 1, 2019 Sep 30, 2019
Q2 2019 -267 -466 -234% Apr 1, 2019 Jun 30, 2019
Q1 2019 2.61K +2.3K +763% Jan 1, 2019 Mar 31, 2019
Q4 2018 329 -9.17K -96.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 179 -1.16K -86.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 199 +340 Apr 1, 2018 Jun 30, 2018
Q1 2018 302 Jan 1, 2018 Mar 31, 2018
Q4 2017 9.5K Oct 1, 2017 Dec 31, 2017
Q3 2017 1.34K Jul 1, 2017 Sep 30, 2017
Q2 2017 -141 Apr 1, 2017 Jun 30, 2017

Organogenesis Holdings Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 0.32 -1.5 -82.7% Jan 1, 2024 Dec 31, 2024
2023 1.81 -4.29 -70.3% Jan 1, 2023 Dec 31, 2023
2022 6.1 -43.6 -87.7% Jan 1, 2022 Dec 31, 2022
2021 49.7 +24.7 +98.5% Jan 1, 2021 Dec 31, 2021
2020 25 +153 Jan 1, 2020 Dec 31, 2020
2019 -128 -457 -139% Jan 1, 2019 Dec 31, 2019
2018 329 -10.3K -96.9% Jan 1, 2018 Dec 31, 2018
2017 10.6K Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.